1.
China Pharmacy
;
(12)2005.
Artículo
en Chino
| WPRIM
| ID: wpr-525424
RESUMEN
OBJECTIVE:To evaluate the efficacy and safety of new agent zaleplon in treatment of insomnia.METHODS:A randomized,double-blind,controlled and dosage-adjusted clinical trial was conducted.The subjects had been treated with zaleplon5~10mg/d and zopicolone7.5~15mg/d for14days,respectively.RESULTS:The scores of sleep dysfunction rating scale at endpoint were significantly reduced as compared with the baseline in both groups(P